OBJECTIVE: Neuronal nitric oxide synthase (nNOS), normally expressed at the sarcolemmal membrane, is known to be mislocalized to the sarcoplasm in several forms of muscular dystrophy. Our objectives were to characterize further the range of patients manifesting aberrant nNOS sarcolemmal immunolocalization and to study nNOS localization in animal models of nondystrophic myopathy. METHODS: We carried out a retrospective cross-sectional study. We performed immunofluorescent staining for nNOS on biopsy specimens from 161 patients with acquired and nondystrophin inherited neuromuscular conditions. The localization of sarcolemmal nNOS correlated with mobility and functional status. Muscle specimens from mouse models of steroid-induced and starvation-related atrophy were studied for qualitative and quantitative nNOS expression. RESULTS: Sarcolemmal nNOS staining was abnormal in 42% of patients with inherited myopathic conditions, 25% with acquired myopathic conditions, 57% with neurogenic conditions, and 93% with hypotonia. Interestingly, we found significant associations between mobility status or muscle function and sarcolemmal nNOS expression. Furthermore, mouse models of catabolic stress also demonstrated mislocalization of sarcolemmal nNOS. CONCLUSION: Our analyses indicate that nNOS mislocalization is observed in a broad range of nondystrophic neuromuscular conditions associated with impaired mobility status and catabolic stress. Our findings suggest that the assessment of sarcolemmal localization of nNOS represents an important tool for the evaluation of muscle biopsies of patients with a variety of inherited and acquired forms of neuromuscular disorders.
OBJECTIVE:Neuronal nitric oxide synthase (nNOS), normally expressed at the sarcolemmal membrane, is known to be mislocalized to the sarcoplasm in several forms of muscular dystrophy. Our objectives were to characterize further the range of patients manifesting aberrant nNOS sarcolemmal immunolocalization and to study nNOS localization in animal models of nondystrophic myopathy. METHODS: We carried out a retrospective cross-sectional study. We performed immunofluorescent staining for nNOS on biopsy specimens from 161 patients with acquired and nondystrophin inherited neuromuscular conditions. The localization of sarcolemmal nNOS correlated with mobility and functional status. Muscle specimens from mouse models of steroid-induced and starvation-related atrophy were studied for qualitative and quantitative nNOS expression. RESULTS: Sarcolemmal nNOS staining was abnormal in 42% of patients with inherited myopathic conditions, 25% with acquired myopathic conditions, 57% with neurogenic conditions, and 93% with hypotonia. Interestingly, we found significant associations between mobility status or muscle function and sarcolemmal nNOS expression. Furthermore, mouse models of catabolic stress also demonstrated mislocalization of sarcolemmal nNOS. CONCLUSION: Our analyses indicate that nNOS mislocalization is observed in a broad range of nondystrophic neuromuscular conditions associated with impaired mobility status and catabolic stress. Our findings suggest that the assessment of sarcolemmal localization of nNOS represents an important tool for the evaluation of muscle biopsies of patients with a variety of inherited and acquired forms of neuromuscular disorders.
Authors: Justin M Percival; Kendra N E Anderson; Paul Huang; Marvin E Adams; Stanley C Froehner Journal: J Clin Invest Date: 2010-03 Impact factor: 14.808
Authors: Yi Lai; Gail D Thomas; Yongping Yue; Hsiao T Yang; Dejia Li; Chun Long; Luke Judge; Brian Bostick; Jeffrey S Chamberlain; Ronald L Terjung; Dongsheng Duan Journal: J Clin Invest Date: 2009-02-23 Impact factor: 14.808
Authors: Yvonne M Kobayashi; Erik P Rader; Robert W Crawford; Nikhil K Iyengar; Daniel R Thedens; John A Faulkner; Swapnesh V Parikh; Robert M Weiss; Jeffrey S Chamberlain; Steven A Moore; Kevin P Campbell Journal: Nature Date: 2008-10-26 Impact factor: 49.962
Authors: Stanley C Froehner; Sarah M Reed; Kendra N Anderson; Paul L Huang; Justin M Percival Journal: Hum Mol Genet Date: 2014-09-11 Impact factor: 6.150
Authors: Daniela L Rebolledo; Min Jeong Kim; Nicholas P Whitehead; Marvin E Adams; Stanley C Froehner Journal: Hum Mol Genet Date: 2015-11-24 Impact factor: 6.150